Department of Physiology, School of MedicineTulane UniversityNew OrleansLouisianaUnited States.
Am J Physiol Renal Physiol. 2024 Sep 1;327(3):F543-F551. doi: 10.1152/ajprenal.00140.2024. Epub 2024 Jul 4.
Sex differences in renal physiology and pathophysiology are now well established in rodent models and in humans. Epigenetic programming is known to be a critical component of renal injury, as studied mainly in male rodent models; however, not much is known about the impact of biological sex and age on the kidney epigenome. We sought to determine the influence of biological sex and age on renal epigenetic and injury markers, using male and female mice at 4 mo (4M; young), 12 mo (12M), and 24 mo (24M; aged) of age. Females had a significant increase in kidney and body weights and serum creatinine levels and a decrease in serum albumin levels from 4M to 24M of age, whereas minor changes were observed in male mice. Kidney injury molecule-1 levels in serum and renal tissue greatly enhanced from 12M to 24M in both males and females. Circulating histone 3 (H3; damage-associated molecular pattern molecules) levels extensively increased with age; however, males had higher levels than females. Overall, females had markedly high histone acetyltransferase (HAT) activity than age-matched males. Aged mice had decreased HAT activity and increased histone deacetylase activity than sex-matched 12M mice. Aged females had substantially decreased renal H3 methylation at lysine 9 and 27 and histone methyltransferase (HMT) activity than aged male mice. Antiaging protein Klotho levels were significantly higher in young males than age-matched females and decreased substantially with age in males, whereas epigenetic repressor of Klotho, trimethylated H3K27, and its HMT enzyme, enhancer of zeste homolog 2, increased consistently with age in both sexes. Moreover, nuclear translocation and activity of proinflammatory transcription factor nuclear factor-κB (p65) were significantly higher in aged mice. Taken together, our data suggest that renal aging lies in a range between normal and diseased kidneys but may differ between female and male mice, highlighting sex-related differences in the aging process. Although there is evidence of sex-specific differences in kidney diseases, most preclinical studies have used male rodent models. The clinical data on renal injury have typically not been stratified by sex. Our findings provide convincing evidence of sex-specific differences in age-regulated epigenetic alterations and renal injury markers. This study highlights the importance of including both sexes for better realization of underlying sex differences in signaling mechanisms of aging-related renal pathophysiology.
性别在肾脏生理和病理生理学方面的差异在啮齿动物模型和人类中已经得到充分证实。已知表观遗传编程是肾脏损伤的一个关键组成部分,主要在雄性啮齿动物模型中进行研究;然而,关于生物性别和年龄对肾脏表观基因组的影响知之甚少。我们试图确定生物性别和年龄对肾脏表观遗传和损伤标志物的影响,使用 4 个月(4M;年轻)、12 个月(12M)和 24 个月(24M;年老)的雄性和雌性小鼠。从 4M 到 24M 年龄,雌性小鼠的肾脏和体重显著增加,血清肌酐水平升高,血清白蛋白水平降低,而雄性小鼠的变化较小。血清和肾组织中的肾脏损伤分子-1 水平在雄性和雌性小鼠中从 12M 到 24M 显著增加。循环组蛋白 3(H3;损伤相关分子模式分子)水平随年龄的增长而广泛增加;然而,雄性的水平高于雌性。总的来说,雌性的组蛋白乙酰转移酶(HAT)活性明显高于年龄匹配的雄性。老年小鼠的 HAT 活性低于性别匹配的 12M 小鼠,而去乙酰化酶活性高于 12M 小鼠。与老年雄性小鼠相比,老年雌性小鼠的肾脏 H3 赖氨酸 9 和 27 甲基化和组蛋白甲基转移酶(HMT)活性显著降低。年轻雄性的抗衰老蛋白 Klotho 水平明显高于年龄匹配的雌性,并且在雄性中随着年龄的增长而显著降低,而 Klotho 的表观遗传抑制剂、三甲基化 H3K27 及其 HMT 酶、增强子 of zeste 同源物 2(enhancer of zeste homolog 2)则随着年龄的增长在两性中持续增加。此外,核转录因子核因子-κB(p65)的促炎转录因子核易位和活性在老年小鼠中显著升高。总之,我们的数据表明,肾脏衰老处于正常和患病肾脏之间的范围,但在雌性和雄性小鼠之间可能有所不同,突出了性别在衰老过程中的差异。尽管有证据表明肾脏疾病存在性别特异性差异,但大多数临床前研究都使用雄性啮齿动物模型。关于肾脏损伤的临床数据通常没有按性别分层。我们的发现提供了令人信服的证据,证明年龄调节的表观遗传改变和肾脏损伤标志物存在性别特异性差异。这项研究强调了包括两性在内的重要性,以便更好地认识与衰老相关的肾脏病理生理学中信号转导机制的潜在性别差异。